
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5241775
[patent_doc_number] => 20070020267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Anti-VEGF antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/414742
[patent_app_country] => US
[patent_app_date] => 2006-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 53921
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020267.pdf
[firstpage_image] =>[orig_patent_app_number] => 11414742
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/414742 | Anti-VEGF antibodies | Apr 26, 2006 | Issued |
Array
(
[id] => 5857955
[patent_doc_number] => 20060228372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Methods for modulating angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/403387
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21249
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228372.pdf
[firstpage_image] =>[orig_patent_app_number] => 11403387
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403387 | Methods for modulating angiogenesis | Apr 12, 2006 | Issued |
Array
(
[id] => 5580910
[patent_doc_number] => 20090176256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Methods and Products for Evaluating an Immune Response to a Therapeutic Protein'
[patent_app_type] => utility
[patent_app_number] => 11/887782
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21571
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176256.pdf
[firstpage_image] =>[orig_patent_app_number] => 11887782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/887782 | Methods and products for evaluating an immune response to a therapeutic protein | Apr 3, 2006 | Issued |
Array
(
[id] => 5753446
[patent_doc_number] => 20060222595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Nanoparticles for therapeutic and diagnostic applications'
[patent_app_type] => utility
[patent_app_number] => 11/392448
[patent_app_country] => US
[patent_app_date] => 2006-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7217
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20060222595.pdf
[firstpage_image] =>[orig_patent_app_number] => 11392448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/392448 | Nanoparticles for therapeutic and diagnostic applications | Mar 28, 2006 | Abandoned |
Array
(
[id] => 318349
[patent_doc_number] => 07521056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-21
[patent_title] => 'Stably tethered structures of defined compositions with multiple functions or binding specificities'
[patent_app_type] => utility
[patent_app_number] => 11/391584
[patent_app_country] => US
[patent_app_date] => 2006-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 45888
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/521/07521056.pdf
[firstpage_image] =>[orig_patent_app_number] => 11391584
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/391584 | Stably tethered structures of defined compositions with multiple functions or binding specificities | Mar 27, 2006 | Issued |
Array
(
[id] => 285217
[patent_doc_number] => 07550143
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses'
[patent_app_type] => utility
[patent_app_number] => 11/389358
[patent_app_country] => US
[patent_app_date] => 2006-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 22372
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550143.pdf
[firstpage_image] =>[orig_patent_app_number] => 11389358
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/389358 | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses | Mar 23, 2006 | Issued |
Array
(
[id] => 177531
[patent_doc_number] => 07655238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Compositions and methods for enhancing the immunogenicity of antigens'
[patent_app_type] => utility
[patent_app_number] => 11/376572
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21299
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655238.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376572
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376572 | Compositions and methods for enhancing the immunogenicity of antigens | Mar 15, 2006 | Issued |
Array
(
[id] => 5785439
[patent_doc_number] => 20060205067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Compositions and methods for enhancing the immunogenicity of antigens'
[patent_app_type] => utility
[patent_app_number] => 11/376564
[patent_app_country] => US
[patent_app_date] => 2006-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21177
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205067.pdf
[firstpage_image] =>[orig_patent_app_number] => 11376564
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/376564 | Compositions and methods for enhancing the immunogenicity of antigens | Mar 15, 2006 | Issued |
Array
(
[id] => 169843
[patent_doc_number] => 07662396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Compositions and methods for enhancing the immunogenicity of antigens'
[patent_app_type] => utility
[patent_app_number] => 11/373528
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 29
[patent_no_of_words] => 24894
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662396.pdf
[firstpage_image] =>[orig_patent_app_number] => 11373528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/373528 | Compositions and methods for enhancing the immunogenicity of antigens | Mar 12, 2006 | Issued |
Array
(
[id] => 5677428
[patent_doc_number] => 20060182783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Sustained release intraocular drug delivery systems'
[patent_app_type] => utility
[patent_app_number] => 11/370301
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 26192
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20060182783.pdf
[firstpage_image] =>[orig_patent_app_number] => 11370301
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/370301 | Sustained release intraocular drug delivery systems | Mar 7, 2006 | Abandoned |
Array
(
[id] => 5618968
[patent_doc_number] => 20060188501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Diagnostic and therapeutic agents for rheumatoid arthritis'
[patent_app_type] => utility
[patent_app_number] => 11/360436
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8068
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188501.pdf
[firstpage_image] =>[orig_patent_app_number] => 11360436
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/360436 | Diagnostic and therapeutic agents for rheumatoid arthritis | Feb 23, 2006 | Abandoned |
Array
(
[id] => 5514275
[patent_doc_number] => 20090214581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'EPITOPE PEPTIDES DERIVED FROM VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 AND VACCINES CONTAINING THESE PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 11/816893
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10207
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214581.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816893
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816893 | Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides | Feb 16, 2006 | Issued |
Array
(
[id] => 5618913
[patent_doc_number] => 20060188446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'T-cell epitope peptides'
[patent_app_type] => utility
[patent_app_number] => 11/354543
[patent_app_country] => US
[patent_app_date] => 2006-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5527
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11354543
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/354543 | T-cell epitope peptides | Feb 13, 2006 | Issued |
Array
(
[id] => 5693733
[patent_doc_number] => 20060153880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Pharmaceutical use of alpha antigen or alpha antigen gene'
[patent_app_type] => utility
[patent_app_number] => 11/352342
[patent_app_country] => US
[patent_app_date] => 2006-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5346
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153880.pdf
[firstpage_image] =>[orig_patent_app_number] => 11352342
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352342 | Pharmaceutical use of alpha antigen or alpha antigen gene | Feb 12, 2006 | Issued |
Array
(
[id] => 5608029
[patent_doc_number] => 20060269545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/348526
[patent_app_country] => US
[patent_app_date] => 2006-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 48153
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269545.pdf
[firstpage_image] =>[orig_patent_app_number] => 11348526
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/348526 | Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof | Feb 6, 2006 | Issued |
Array
(
[id] => 5608029
[patent_doc_number] => 20060269545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/348526
[patent_app_country] => US
[patent_app_date] => 2006-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 48153
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20060269545.pdf
[firstpage_image] =>[orig_patent_app_number] => 11348526
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/348526 | Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof | Feb 6, 2006 | Issued |
Array
(
[id] => 5171325
[patent_doc_number] => 20070071756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Delivery of an agent to ameliorate inflammation'
[patent_app_type] => utility
[patent_app_number] => 11/348017
[patent_app_country] => US
[patent_app_date] => 2006-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6180
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20070071756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11348017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/348017 | Delivery of an agent to ameliorate inflammation | Feb 5, 2006 | Abandoned |
Array
(
[id] => 5172500
[patent_doc_number] => 20070072933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Delivery of an ocular agent'
[patent_app_type] => utility
[patent_app_number] => 11/348465
[patent_app_country] => US
[patent_app_date] => 2006-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7913
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11348465
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/348465 | Delivery of an ocular agent | Feb 5, 2006 | Abandoned |
Array
(
[id] => 5842196
[patent_doc_number] => 20060121025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'VEGF-related protein'
[patent_app_type] => utility
[patent_app_number] => 11/346806
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25887
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121025.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346806
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346806 | VEGF-related protein | Feb 2, 2006 | Abandoned |
Array
(
[id] => 4681804
[patent_doc_number] => 20080248030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Method of Treating Angiogenic Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/883501
[patent_app_country] => US
[patent_app_date] => 2006-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8413
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883501
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883501 | Method of Treating Angiogenic Diseases | Feb 1, 2006 | Abandoned |